Personalis, Inc. (NASDAQ:PSNL - Get Free Report)'s share price was down 7.4% during mid-day trading on Tuesday . The stock traded as low as $5.65 and last traded at $5.70. Approximately 983,709 shares were traded during mid-day trading, a decline of 7% from the average daily volume of 1,056,524 shares. The stock had previously closed at $6.15.
Analysts Set New Price Targets
A number of equities analysts have recently commented on the stock. Needham & Company LLC reissued a "buy" rating and issued a $7.00 target price on shares of Personalis in a research note on Thursday, April 10th. HC Wainwright raised their price objective on Personalis from $8.00 to $9.00 and gave the company a "buy" rating in a research report on Wednesday, May 7th. Finally, Guggenheim initiated coverage on Personalis in a research note on Thursday, May 15th. They set a "buy" rating and a $6.00 price objective on the stock. Six analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $7.67.
Get Our Latest Report on PSNL
Personalis Stock Down 1.6%
The firm's 50 day moving average price is $6.06 and its two-hundred day moving average price is $4.92. The firm has a market capitalization of $476.04 million, a PE ratio of -4.18 and a beta of 1.86.
Personalis (NASDAQ:PSNL - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported ($0.18) earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.05. The company had revenue of $20.61 million during the quarter, compared to analysts' expectations of $17.41 million. Personalis had a negative net margin of 98.10% and a negative return on equity of 48.78%. On average, sell-side analysts anticipate that Personalis, Inc. will post -1.4 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Personalis
A number of hedge funds have recently bought and sold shares of the business. Raymond James Financial Inc. purchased a new position in shares of Personalis during the 4th quarter valued at approximately $64,000. American Century Companies Inc. raised its holdings in Personalis by 98.8% in the fourth quarter. American Century Companies Inc. now owns 50,321 shares of the company's stock valued at $291,000 after acquiring an additional 25,011 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Personalis by 2,827.0% during the 4th quarter. JPMorgan Chase & Co. now owns 5,854 shares of the company's stock valued at $34,000 after acquiring an additional 5,654 shares during the last quarter. Trexquant Investment LP acquired a new position in Personalis during the 4th quarter worth $128,000. Finally, ExodusPoint Capital Management LP acquired a new position in Personalis during the 4th quarter worth $133,000. Institutional investors and hedge funds own 61.91% of the company's stock.
About Personalis
(
Get Free Report)
Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.
Featured Articles
Before you consider Personalis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Personalis wasn't on the list.
While Personalis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access